Several recent studies have shown the possibilities in this field
People with a BMI of 30 or higher or a BMI of 27 or higher with weight-related health conditions like type 2 diabetes or high blood pressure are typically eligible
These new treatment possibilities for clinicians, coupled with an increase in industry marketing and patients personal needs, have led to an explosion of prescriptions for these drugs especially in Western countries [9]
While the weight loss outcomes of semaglutide and other GLP-1-RA drugs are widely documented, the underlying mechanism is not fully understood
What I found that most people misunderstand is that up to half the medical literature is wrong, he said, noting that papers will often be published about scientific debates or clinical studies that may not ultimately pan out
They activate receptors throughout the brain, gut, and endocrine system, potentially affecting serotonin, dopamine, and stress hormone signaling